{"id":23638,"date":"2025-12-18T23:23:47","date_gmt":"2025-12-18T17:53:47","guid":{"rendered":"http:\/\/43.205.138.160\/?post_type=article&p=23638"},"modified":"2025-12-18T23:23:47","modified_gmt":"2025-12-18T17:53:47","slug":"auropharma-injecting-growth-from-supports-to-stratospheric-gains","status":"publish","type":"article","link":"https:\/\/signalz.pro\/article\/auropharma-injecting-growth-from-supports-to-stratospheric-gains\/","title":{"rendered":"“AUROPHARMA: Injecting Growth \u2013 From Supports to Stratospheric Gains.”"},"content":{"rendered":"

Stock Outlook:
\n<\/strong>Aurobindo Pharma (AUROPHARMA) exhibited robust intraday buying on December 18, 2025, opening at \u20b91190, hitting high \u20b91213.70 (+2%), low \u20b91176.60 (-1.15%), and closing at \u20b91209.30 (+1.37%) with 947k volume (1.4x 20D avg) and 52% delivery, signaling strong hands interest amid pharma rebound. Detailed technicals reveal strong buy oscillators overriding bearish MAs, supported by Q2 FY26 revenue growth to \u20b98286 Cr despite FDA procedural observations. Fundamentals underscore value at P\/E 20.52 (sector low), low debt, and injectables expansion potential.<\/p>\n

Detailed Technical Analysis:
\n<\/strong>Oscillators (Strong Buy): RSI(14) 49 neutral-bullish, STOCH(9,6) 72 buy, STOCHRSI(14) 100 overbought-buy, Williams %R -44 buy, CCI(14) 128 buy; MACD(12,26) -2.9 sell but histogram narrowing. ADX(14) 24 neutral, ATR(14) 9.46 high volatility favors breakouts.\u200b
\nMoving Averages (Bearish, but turning): 3 buy\/9 sell\u2014MA5 \u20b91120 sell, MA10 \u20b91145 sell, MA20 \u20b91172 sell, MA50 \u20b91130 sell, MA100 \u20b91165 sell, MA200 \u20b91139 sell. Price above short-term EMAs signals intraday strength; golden cross potential if MA20 crosses MA50.
\nPivot & Intraday Action: Classic pivots: R3 \u20b91227, R2 \u20b91217, R1 \u20b91211, Pivot \u20b91202, S1 \u20b91192, S2 \u20b91182, S3 \u20b91172. Stock broke R1 \u20b91206 on volume, closed near R2 with doji-like candle hinting continuation; VWAP \u20b91202 hold key for bulls.\u200b
\nChart Patterns & Outlook: Rounding bottom from \u20b91130 lows, Fibonacci 61.8% retrace at \u20b91180 support. Bullish divergence on RSI vs price; target \u20b91230 (R3) short-term, \u20b91356 52W high long-term if breaks MA50 with volume >1M.<\/p>\n

Detailed Fundamental Analysis:
\n<\/strong>Q2 FY26 Results (Nov 2025): Revenue \u20b98286 Cr (+6% YoY, +5% QoQ), EBITDA \u20b91687 Cr (margin 20.37% vs 21.38% prior, -101 bps), PAT \u20b9848 Cr (+3% YoY). H1 FY26: Sales \u20b916,154 Cr, profit \u20b91673 Cr. US generics 47% revenue (stable), Europe +12%, ARV +15%.\u200b
\nValuations & Ratios: Market cap \u20b970,236 Cr, P\/E 20.52 (sector 39.68), forward P\/E 17.5, P\/B 2.16 (sector 4.2), EV\/EBITDA 11.2. ROE 10.67% (sector 12%), ROCE 13.2%, debt\/equity 0.24 low, current ratio 1.8. Dividend yield 0.49%, EPS TTM \u20b958.93 (-4% YoY).\u200b
\nGrowth Drivers: Injectables capex reset to \u20b91500 Cr FY26 (up from \u20b91000 Cr), Merck CDMO roadmap, Kakinada SEZ port infra for exports. Promoter holding 51.74% steady, FII 19.2% up QoQ.<\/p>\n

Auropharma Positive & Negative Points:
\n<\/strong>Price\/Volume: +1.37% gain with 52% delivery and 1.4x volume breakout above R1; countered by YTD -3.2% lag, trading below 52W high \u20b91356 near MA20.\u200b
\nTechnicals: 6\/8 oscillators signal buy with pivot \u20b91202 hold; offset by 9\/12 MAs sell and negative MACD.\u200b
\nFinancials: Low P\/E 20.5, +6% revenue, minimal debt shine; EBITDA margin dipped -101 bps with EPS -4% YoY.\u200b
\nOperations: Injectables\/CDMO growth and Europe +12% boost prospects; US FDA Form 483 (5 procedural obs) adds caution.<\/p>\n

Buying Reason, News & Impact:
\n<\/strong>Today’s Surge: Pharma index +0.8% rebound, high delivery amid Q2 momentum carryover (PAT beat estimates), short-covering post-FDA dip. No specific Dec 18 trigger; sector rotation from IT to pharma on global cues.\u200b
\nKey News\/Event: US FDA inspected APL Healthcare Unit-IV (Dec 8-17, 2025): 5 procedural observations (no data integrity issues)\u2014company filing response by Jan 2026; historical procedural fixes resolved quickly, minimal impact (stock -2% post-news, recovered). Positive: Injectables bet, FY26 guidance 12-14% revenue growth. Impact: Neutral-short term (regulatory overhang caps), bullish medium-term on diversification.<\/p>\n

Short & Long-Term Levels:
\n<\/strong>Short-Term (1-4 weeks): Buy \u20b91180-1192 (S1-S2, Fib 61.8%), target \u20b91211-1227 (R1-R3), stop \u20b91172. Hold above \u20b91202 pivot.\u200b
\nLong-Term (6-12 months): Support \u20b91130-1160 (MA50\/200 cluster), target \u20b91300-1430 (Analyst avg, 20% upside). Bullish above \u20b91248 breakout.\u200b<\/p>\n

Disclaimer & Disclosure:
\n<\/strong>Educational content only; not investment advice or recommendation. No positions held; data from public sources as of Dec 18, 2025, 11 PM IST. Markets volatile\u2014consult SEBI-registered advisor.
\nPast performance no future guarantee.<\/p>\n","protected":false},"template":"","article-category":[35],"article-tags":[787,761,385,400,130,163,121,169,92,116,129,127,155],"class_list":["post-23638","article","type-article","status-publish","hentry","article-category-learn","article-tags-nifty-banknifty","article-tags-nifty-banknifty-optiondata","article-tags-optionbuying","article-tags-technicalanalysis","article-tags-expert-analysis","article-tags-financialeducation","article-tags-investment-opportunities","article-tags-investmentstrategy","article-tags-sebi-registered-advisors","article-tags-signalzinvestmenttips","article-tags-stock-market-tips","article-tags-successful-investing","article-tags-wealthbuilding"],"acf":[],"_links":{"self":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article\/23638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article"}],"about":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media?parent=23638"}],"wp:term":[{"taxonomy":"article-category","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article-category?post=23638"},{"taxonomy":"article-tags","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article-tags?post=23638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}